Irreversible sensorineural hearing loss due to Imatinib
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference5 articles.
1. Five-year data on imatinib show best-ever survival with chronic myeloid leukemia;Druker;N Engl J Med,2006
2. Cardiotoxicity of the cancer therapeutic agent Imatinib mesylate;Kerkela;Nat Med,2006
3. Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia;Govind Babu;Int Ophthalmol,2007
4. Imatinib mesylate (Gleevec) induces mitochondrial dysfunction and caspase activation in cardiac myocytes;Grazette;J Card Fail,2005
5. Dasatinib in Imatinib-resistant Philadelphia chromosome-positive leukemia;Talpaz;N Engl J Med,2006
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Coexisting of hearing loss and chronic myeloid leukemia - A systematic literature review;F1000Research;2024-08-28
2. The Pathological Mechanisms of Hearing Loss Caused by KCNQ1 and KCNQ4 Variants;Biomedicines;2022-09-12
3. Putative COVID-19 therapies imatinib, lopinavir, ritonavir, and ivermectin cause hair cell damage: A targeted screen in the zebrafish lateral line;Frontiers in Cellular Neuroscience;2022-08-24
4. Ototoxicity Review: A Growing Number of Non–Platinum‐Based Chemo‐ and Immunotherapies;Otolaryngology–Head and Neck Surgery;2022-04-19
5. Cell death-inducing cytotoxicity in truncated KCNQ4 variants associated with DFNA2 hearing loss;Disease Models & Mechanisms;2021-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3